DEFA14A: 180 Life Sciences Corp. to Hold Annual Meeting on December 27, 2024

180 Life Sciences Corp. announces its Annual Meeting of Stockholders to be held on December 27, 2024, to vote on director elections, incentive plan amendments, executive compensation, stock issuance approvals, auditor ratification, and other business.

Summary

• 180 Life Sciences Corp. will hold its Annual Meeting of Stockholders on December 27, 2024.
• Stockholders will vote to elect three Class II directors to the Board for two-year terms.
• The meeting will also address the adoption of the Third Amendment to the 180 Life Sciences Corp. 2022 Omnibus Incentive Plan.
• An advisory resolution on Named Executive Officer compensation will be voted on.
• Stockholders will vote to approve the issuance of more than 20% of the Company's issued and outstanding common stock upon the conversion of Series B Convertible Preferred Stock to comply with Nasdaq Listing Rules 5635(a) and (b).
• Stockholders will vote to approve the issuance of more than 20% of the Company's issued and outstanding common stock upon the exercise of outstanding warrants to purchase shares of common stock to comply with Nasdaq Listing Rules 5635(a) and (b).
• The appointment of M&K CPAs, PLLC as the Company's independent auditors for the fiscal year ending December 31, 2024, will be ratified.
• The record date for determining stockholders entitled to vote is October 31, 2024.
• The Board of Directors recommends voting for all proposals.

Sentiment

Score: 7

Explanation: The document is a standard proxy statement, indicating a neutral to slightly positive sentiment as it reflects the company's adherence to corporate governance practices.

Positives

• The Board of Directors is actively seeking shareholder input on key governance matters.
• The proposals include items related to executive compensation and equity plans, which can be seen as efforts to align management incentives with shareholder value.

Risks

• Failure to secure shareholder approval for the proposals could lead to non-compliance with Nasdaq listing rules or impact the company's ability to attract and retain key personnel through incentive plans.

Future Outlook

The company is seeking shareholder approval for several proposals that will impact its governance and financial structure.

Management Comments

• The Board of Directors recommends that you vote for all proposals.

Industry Context

This announcement is a routine part of corporate governance, ensuring shareholders have a voice in key decisions.

Stakeholder Impact

• Shareholders have the opportunity to influence the company's direction through voting.
• The outcome of the votes could impact executive compensation and the company's ability to comply with Nasdaq listing rules.

Next Steps

• Stockholders should review the proxy materials and vote on the proposals.
• The company will hold the Annual Meeting on December 27, 2024.

Key Dates

Keywords

Annual Meeting, Proxy Statement, Stockholders, Board of Directors, Director Election, Executive Compensation, Incentive Plan, Nasdaq Listing Rules, Auditor Ratification, Common Stock, Warrants, Series B Convertible Preferred Stock